Latest Schedule 13D activist filings

Paolo Tiramani, Co-CEO and Director of Boxabl Inc., has increased his beneficial ownership to 94.8% of the company's Class A Common Stock, primarily through shares held in various trusts.

Telos Corporation CEO John B. Wood has disclosed beneficial ownership of 9.1% of the company's common stock, attributing a late filing to administrative error.

Galiano Paolo Tiramani reports beneficial ownership of 60,052,681 shares, representing 86.5% of Class A Common Stock, with specific lock-up provisions detailed.

Redwood Capital Management, LLC and its affiliates have increased their beneficial ownership of Office Properties Income Trust common shares to 19.7% following the company's emergence from bankruptcy.

Saba Capital Management, L.P. has increased its beneficial ownership of Royce Micro-Cap Trust, Inc. common shares to 6.08%, acquiring an additional 3,252,976 shares.

Kira S. Sheinerman has filed a Schedule 13D, reporting beneficial ownership of 1,515,293 shares, or 51.56%, of Niki BioSolutions, Inc. common stock, acquired as merger consideration.

NaaS Technology Inc. announces a significant share acquisition, issuing 16 billion Class A shares to Newlink Digital Energy Holding Limited.

Choo Chee Kong, Chairman and Director of CytoMed Therapeutics Ltd, has amended his Schedule 13D filing to report beneficial ownership of 2,899,746 Ordinary Shares, representing 24.30% of the company's outstanding stock.

Franklin Resources, Inc. and its subsidiaries have amended their Schedule 13D filing to report beneficial ownership of 27.5% of Clarion Partners Real Estate Income Fund Inc.'s Class I Shares.

Franklin Resources, Inc. and its subsidiaries have amended their Schedule 13D filing to report beneficial ownership of 27.5% of Clarion Partners Real Estate Income Fund Inc.'s Class I Shares.

Glory Achievement Fund Limited, Bull Group Limited, and BULL TRUST have jointly filed an amended Schedule 13D, reporting combined beneficial ownership of 41.9% of Niu Technologies' Class A ordinary shares.

RA Capital Management and its affiliates have disclosed an increased beneficial ownership stake in Artiva Biotherapeutics, Inc. to 37.9% through recent open market purchases.

Brookfield Infrastructure Corporation announces a significant corporate restructuring to simplify its structure into a single Canadian entity, BIP Inc., with meetings scheduled for October 14, 2026.

Brookfield Infrastructure Corporation announces a significant corporate restructuring to simplify its structure into a single Canadian entity, BIP Inc., with meetings scheduled for October 14, 2026.

Brookfield Infrastructure Partners L.P. announces a significant corporate restructuring to simplify its structure into a single Canadian publicly traded entity.

Brookfield Infrastructure Partners L.P. announces a significant corporate restructuring to simplify its structure into a single Canadian publicly traded entity.

Glenbrook Capital Management has filed a Schedule 13D, reporting beneficial ownership of 19.95% of SenesTech, Inc. common stock, acquired for investment purposes.

Brookfield Renewable Corporation announces a significant corporate restructuring plan to simplify its structure into a single Canadian entity, with meetings scheduled for October 14, 2026.

Brookfield Renewable Corporation announces a significant corporate restructuring plan to simplify its structure into a single Canadian entity, with meetings scheduled for October 14, 2026.

Brookfield Renewable Partners L.P. announces a significant corporate restructuring to simplify its structure into a single Canadian public entity.

Brookfield Renewable Partners L.P. announces a significant corporate restructuring to simplify its structure into a single Canadian public entity.

Michael Bernard Hess, SS3H Ventures LLC, and Kelly J. Engel have jointly filed a Schedule 13D, reporting beneficial ownership of Metals Royalty Co Inc. common shares.

RTW Investments, LP and Roderick Wong, M.D. have filed an amendment to their Schedule 13D, detailing a recent share exchange and warrant agreement with Allurion Technologies, Inc.

Electrum Strategic Resources and Thomas S. Kaplan enter voting agreements supporting NOVAGOLD's acquisition by NovaGold Corporation.

Al Shams Investments, Braemar's largest shareholder, issues a statement refuting management's claims and highlighting concerns over corporate governance and executive compensation.

DEFJ, LLC and CK Life Sciences Int'l. (Holdings) Inc. report a conversion of Series B Preferred Stock into common stock, bringing their beneficial ownership to 9.9% of TransCode Therapeutics.

Askeladden Capital Management and Samir Patel have reduced their stake in AstroNova, Inc. to below the 5% reporting threshold, citing the company's pending acquisition.

Olesen Value Fund L.P. and associated entities have filed a Schedule 13D, reporting beneficial ownership of 10.1% of Solitron Devices Inc. common stock, acquired for investment purposes.

Michael Field has increased his beneficial ownership of HST Global, Inc. common stock to 31%, acquiring an additional 43,441,573 shares through a shareholder rights offering.

Gerald J. Ford and associated entities are seeking to enforce a settlement agreement related to Hilltop Holdings shares amidst a shareholder dispute.